NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics,
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
THOUSAND OAKS, Calif., Sept. 6, 2018 /PRNewswire/ — Amgen (NASDAQ: